Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195


Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.

Zhang X, Guo J, Fan S, Li Y, Wei L, Yang X, Jiang T, Chen Z, Wang C, Liu J, Ping Z, Xu D, Wang J, Li Z, Qiu Y, Li JC.

PLoS One. 2013 Dec 5;8(12):e81076. doi: 10.1371/journal.pone.0081076. eCollection 2013.


Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection.

Qi Y, Cui L, Ge Y, Shi Z, Zhao K, Guo X, Yang D, Yu H, Cui L, Shan Y, Zhou M, Wang H, Lu Z.

BMC Infect Dis. 2012 Dec 28;12:384. doi: 10.1186/1471-2334-12-384.


Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.

Tan Y, Ge G, Pan T, Wen D, Gan J.

Clin Chim Acta. 2015 Dec 7;451(Pt B):232-9. doi: 10.1016/j.cca.2015.10.002. Epub 2015 Oct 17.


Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia.

Abd-El-Fattah AA, Sadik NA, Shaker OG, Aboulftouh ML.

Cell Biochem Biophys. 2013;67(3):875-84. doi: 10.1007/s12013-013-9575-y.


Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.

Ouyang X, Jiang X, Gu D, Zhang Y, Kong SK, Jiang C, Xie W.

Int J Med Sci. 2016 Feb 18;13(3):195-205. doi: 10.7150/ijms.13996. eCollection 2016.


A Group of Novel Serum Diagnostic Biomarkers for Multidrug-Resistant Tuberculosis by iTRAQ-2D LC-MS/MS and Solexa Sequencing.

Wang C, Liu CM, Wei LL, Shi LY, Pan ZF, Mao LG, Wan XC, Ping ZP, Jiang TT, Chen ZL, Li ZJ, Li JC.

Int J Biol Sci. 2016 Jan 1;12(2):246-56. doi: 10.7150/ijbs.13805. eCollection 2016.


Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.

Qian BP, Ji ML, Qiu Y, Wang B, Yu Y, Shi W, Luo YF.

Spine (Phila Pa 1976). 2016 May;41(9):735-42. doi: 10.1097/BRS.0000000000001339.


Circulating microRNAs in patients with active pulmonary tuberculosis.

Fu Y, Yi Z, Wu X, Li J, Xu F.

J Clin Microbiol. 2011 Dec;49(12):4246-51. doi: 10.1128/JCM.05459-11. Epub 2011 Oct 12.


Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.

Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.

Tumour Biol. 2016 Jun;37(6):7777-84. doi: 10.1007/s13277-015-4608-3. Epub 2015 Dec 22.


Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.

Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W.

Int J Med Sci. 2015 Jul 16;12(7):590-8. doi: 10.7150/ijms.11525. eCollection 2015.


Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.

Dong R, Shen Z, Zheng C, Chen G, Zheng S.

Sci Rep. 2016 Feb 16;6:21084. doi: 10.1038/srep21084.


A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.

Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, Zhou X, Gan J.

PLoS One. 2014 Sep 19;9(9):e107986. doi: 10.1371/journal.pone.0107986. eCollection 2014.


Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.

Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G, Qu A, Wang H, Wang L, Zhang X, Liu H, Pan H, Yang Y, Wang C.

Mol Med Rep. 2015 Jul;12(1):615-22. doi: 10.3892/mmr.2015.3428. Epub 2015 Mar 4.


Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes.

Yan S, Wang T, Huang S, Di Y, Huang Y, Liu X, Luo Z, Han W, An B.

Acta Diabetol. 2016 Oct;53(5):693-702. doi: 10.1007/s00592-016-0837-1. Epub 2016 Apr 2.


Circulating microRNAs as biomarkers of adult Crohn's disease.

Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1038-44. doi: 10.1097/MEG.0000000000000430.


High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.

Leidinger P, Brefort T, Backes C, Krapp M, Galata V, Beier M, Kohlhaas J, Huwer H, Meese E, Keller A.

Oncotarget. 2016 Jan 26;7(4):4611-23. doi: 10.18632/oncotarget.6566.


miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.

Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.

J Thorac Oncol. 2011 Mar;6(3):482-8. doi: 10.1097/JTO.0b013e318208c785.


A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.

Tan Y, Ge G, Pan T, Wen D, Gan J.

PLoS One. 2014 Aug 20;9(8):e105192. doi: 10.1371/journal.pone.0105192. eCollection 2014.


Serum microRNAs as potential biomarkers of primary biliary cirrhosis.

Tan Y, Pan T, Ye Y, Ge G, Chen L, Wen D, Zou S.

PLoS One. 2014 Oct 27;9(10):e111424. doi: 10.1371/journal.pone.0111424. eCollection 2014.


miRNA signatures in sera of patients with active pulmonary tuberculosis.

Miotto P, Mwangoka G, Valente IC, Norbis L, Sotgiu G, Bosu R, Ambrosi A, Codecasa LR, Goletti D, Matteelli A, Ntinginya EN, Aloi F, Heinrich N, Reither K, Cirillo DM.

PLoS One. 2013 Nov 21;8(11):e80149. doi: 10.1371/journal.pone.0080149. eCollection 2013.

Supplemental Content

Support Center